Back
Speaker illustration

Doctor Xiaojun Wang

Eli Lilly & Co, Indianapolis (United States of America)

Member of:

Heart Failure Association

Presentations

Long-acting relaxin (LY3540378) demonstrates improved renal hemodynamics response in preclinical and clinical studies

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 6

Access
Like
Thumbnail

Discovery and characterization of a long-acting relaxin analog, LY3540378, for the treatment of chronic heart failure

Event: Heart Failure 2022

Topic: Drugs, Drug Targets

Session: Heart Failure ePosters - focus on Basic Science

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources